Tirzepatide
Dual GIP/GLP-1 agonist for advanced metabolic research.
Research chemical · Not for human use
$129.99
Download sample COAResearch description
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Research explores its unique dual-receptor mechanism in metabolic and energy homeostasis studies.
Intended solely as a laboratory reference material. No claims are made regarding safety, efficacy, or suitability for any clinical, therapeutic, or personal use.
Research Applications
- Dual GIP/GLP-1 receptor studies
- Energy expenditure and adiposity models
- Insulin sensitivity research
- Comparative agonist efficacy assays
Storage
- Lyophilized
- -20°C
- Reconstituted
- 2–8°C, 21 days
Laboratory reconstitution
- Recommended diluent
- Bacteriostatic water
- Concentration
- 2 mg/mL
Guidance for in vitro laboratory preparation only — not dosing or administration instructions.
Related research materials
Semaglutide
RUO · Lab research only
GLP-1 receptor agonist for metabolic pathway research.
Retatrutide
RUO · Lab research only
Triple agonist (GIP/GLP-1/Glucagon) reference material for metabolic pathway research.
Cagrilintide
RUO · Lab research only
Amylin analog for metabolic signaling pathway research.